Laboratory Corp. of America Holdings, commonly known as LabCorp, is a leading healthcare diagnostics company. It was founded in 1978 and is headquartered in Burlington, North Carolina. LabCorp operates a vast network of laboratories and offers a comprehensive range of clinical laboratory services, including routine testing, genetic and molecular testing, oncology testing, and clinical trial services. The company serves healthcare providers, pharmaceutical companies, government agencies, and employers by providing accurate and timely diagnostic information to aid in patient care and medical research.
LabCorp is listed on the New York Stock Exchange (NYSE) under the ticker symbol "LH." The company has made notable investments in technology and innovation to enhance its testing capabilities and expand its service offerings. LabCorp has developed and adopted advanced diagnostic technologies, including molecular and genetic testing, which enable more precise and personalized patient care.
LabCorp has also been at the forefront of diagnostic advancements during public health crises. The company played a crucial role in responding to the COVID-19 pandemic by quickly developing and deploying diagnostic tests for the detection of the virus. LabCorp's contributions in scaling up testing capacity and providing accurate and timely COVID-19 test results have been essential in the global effort to manage the pandemic.
Furthermore, LabCorp has actively pursued strategic acquisitions and partnerships to expand its geographic presence and service offerings. These initiatives have enabled the company to broaden its capabilities and provide an extensive range of diagnostic services to a larger customer base. LabCorp's acquisitions have helped it enter new markets, strengthen its position in existing markets, and enhance its ability to deliver innovative diagnostic solutions.